Patent ID: 11919923
Assignee: XINJIANG TECHNICAL INSTITUTE OF PHYSICS & CHEMISTRY. CHINESE ACADEMY OF SCIENCES
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 21:
22. A method for (a) inhibiting replication of a virus; or (b) treating or preventing, or alleviating a disease caused by a virus infection, wherein the method comprises administrating a safe and effective amount of an active ingredient or a formulation containing the active ingredient or a pharmaceutical composition comprising the active ingredient and pharmaceutically acceptable carriers;
wherein:
the active ingredient is a compound according to claim 8, or a pharmaceutically acceptable salt thereof; and
the virus is selected from the group consisting of:
(1) coronavirus infecting human;
(2) human respiratory syncytial virus (RSV);
(3) flaviviridae virus that is selected from dengue virus (DENV), Zika virus (Zika); and
(4) coronavirus infecting porcine that is porcine epidemic diarrhea virus (PEDV).